Intensive antihypertensive therapy in patients with type 2 diabetes reduces mortality and major vascular events irrespective of baseline blood pressure or cardiovascular disease (CVD) risk, Australian research shows. A post-hoc analysis of the ADVANCE trial data showed treatment with a fixed-dose combination of perindopril-indapamide reduced all-cause mortality (HR 0.86) and major microvascular and macrovascular events ...
Good BP control as important as glucose control in T2D
By Mardi Chapman
2 May 2019